Results 191 to 200 of about 63,671 (294)
Clinical and Experimental Neuroimmunology, EarlyView.Abstract Objective Fingolimod is the first oral sphingosine‐1‐phosphate receptor modulator approved in Japan for multiple sclerosis (MS). A large Japanese observational study of fingolimod in patients with MS was carried out to support its safety and effectiveness in a real‐world setting.
Noriko Sato +7 more
wiley +1 more source
A Severe Case of Nuclear Matrix Protein-2-Positive Dermatomyositis With Negative Malignancy Workup. [PDF]
CureusKondle S, Cohen S.
europepmc +1 more source
Clinical and Experimental Neuroimmunology, EarlyView.Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka +4 more
wiley +1 more source
Azathioprine for people with multiple sclerosis. [PDF]
Cochrane Database Syst RevRidley B +5 more
europepmc +1 more source
Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR). [PDF]
, 1984 SA Al‐Safi, JL Maddocks
openalex +1 more source
Infliximab in Autoimmune Inner Ear Disease: A Case Report. [PDF]
Clin Case RepMillan P, Sunmboye KO.
europepmc +1 more source
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. [PDF]
, 1980 Paul D. Lewis +3 more
openalex +1 more source
Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients
Australasian Journal of Dermatology, EarlyView.
Vera Y. Miao +3 more
wiley +1 more source
Efficacy and safety of azathioprine in patients with Cronkhite-Canada syndrome: a case series from Peking Union Medical College Hospital. [PDF]
BMC Pharmacol ToxicolXu Q +10 more
europepmc +1 more source